<DOC>
	<DOCNO>NCT00325468</DOCNO>
	<brief_summary>An Open-label , Single-arm Extension Study Evaluate Long-term Safety Denosumab Administration Postmenopausal Women Low Bone Mineral Density</brief_summary>
	<brief_title>An Open-label , Single-arm Extension Study Evaluate Long-term Safety Denosumab Administration Postmenopausal Women With Low Bone Mineral Density</brief_title>
	<detailed_description />
	<mesh_term>Denosumab</mesh_term>
	<criteria>Subject must ambulatory Subject must atteneded 20010223 endofstudy visit complete test procedure endofstudy visit sign informed consent must obtain studyspecific procedure Experienced severe and/or serious adverse event think related denosumab administration 20010223 study . Developed grade 3 4 laboratory abnormality base Common Terminology Criteria Adverse Events v3.0 20010223 study normalize upon follow diagnosis treatment . Newly diagnose condition hyper/hypo thyroidism , rheumatoid arthritis , bone disease , renal disease . Using therapy participate 20010223 study oral bisphosphonates , calcitonin , oral strontium , SERMS , systemic glucocortiocosteriods .</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>bone loss</keyword>
	<keyword>osteoporosis</keyword>
</DOC>